COMETRIQ vs DANZITEN

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. COMETRIQ and DANZITEN are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	COMETRIQ	DANZITEN
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	CABOZANTINIB S-MALATE	NILOTINIB TARTRATE
Manufacturer	Exelixis	Azurity
Dosage forms	Capsule, Kit	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Renal Cell Carcinoma	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

cometriq danziten

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

CABOZANTINIB S-MALATE

NILOTINIB TARTRATE

Manufacturer

Exelixis

Azurity

Dosage forms

Capsule, Kit

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Renal Cell Carcinoma

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

Frequently asked questions

What is the difference between Cometriq and Danziten?

Cometriq contains Cabozantinib S-Malate, while Danziten contains Nilotinib Tartrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.